These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4385733)

  • 1. A study of electromyographic findings in patients with progressive muscular dystrophy during remetabolizing therapy.
    Buscaino GA; Caruso G
    Acta Neurol (Napoli); 1966; 21(1):33-45. PubMed ID: 4385733
    [No Abstract]   [Full Text] [Related]  

  • 2. [Our experience in the treatment of progressive muscular dystrophy].
    Buscaino GA
    Acta Neurol (Napoli); 1966; 21(2):133-50. PubMed ID: 5961587
    [No Abstract]   [Full Text] [Related]  

  • 3. [Behavior of electromyographic findings in subjects with progressive muscular dystrophy during remetabolizing therapy].
    Buscaino GA; Caruso G
    Riv Patol Nerv Ment; 1965 Apr; 86(2):261-7. PubMed ID: 5883603
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experience with and considerations on therapy of progressive muscular dystrophies].
    Beckmann R
    Hippokrates; 1968 Dec; 39(23):876-88. PubMed ID: 5718770
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the treatment of progressive muscle dystrophy with an anabolic steroid].
    Ernst K
    Z Arztl Fortbild (Jena); 1966 Apr; 60(7):389-90. PubMed ID: 5983564
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of Erb's progressive muscular dystrophy].
    Suchenwirth R
    Munch Med Wochenschr; 1972 Jun; 114(22):1071. PubMed ID: 5068025
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of progressive muscular dystrophy with anabolics and uridine-5-triphosphoric acid].
    Valente VL; Caprarulo CC; Luchetta MR; Nenkies L; Miani J; De Zubizarreta CS
    Prensa Med Argent; 1966 May; 53(20):1130-4. PubMed ID: 5916532
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on progressive muscular dystrophy. IV. Effects of original amino acids mixture on progressive muscular dystrophy.
    Nakahara M; Yamada S
    Arzneimittelforschung; 1967 Jun; 17(6):753-6. PubMed ID: 5632380
    [No Abstract]   [Full Text] [Related]  

  • 9. [THE BEHAVIOR OF SERUM ALDOLASE AND TRANSAMINASE ACTIVITY IN PROGRESSIVE MUSCULAR DYSTROPHY IN BASIC CONDITIONS AND AFTER ANABOLIC AND RE-METABOLIZING THERAPY].
    BUSCAINO GA; SEPE O
    Acta Neurol (Napoli); 1964; 19():523-46. PubMed ID: 14208396
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical investigation in Duchenne muscular dystrophy: penicillamine and vitamin E.
    Fenichel GM; Brooke MH; Griggs RC; Mendell JR; Miller JP; Moxley RT; Park JH; Provine MA; Florence J; Kaiser KK
    Muscle Nerve; 1988 Nov; 11(11):1164-8. PubMed ID: 3067086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [On the enzymatic differential diagnosis of the involvement of various organs in Erb's progressive muscular dystrophy during three medications].
    Kleine TO; Chlond H
    Enzymol Biol Clin (Basel); 1969; 10(1):39-67. PubMed ID: 5305371
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anabolic steroid hormones and progressive muscular dystrophy].
    Beckmann R
    Dtsch Med Wochenschr; 1972 Feb; 97(6):213. PubMed ID: 5058209
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy and macroergic phosphoric compounds in Duchenne's progressive muscular dystrophy].
    Radu H; Stenzel K; Blücher G; Gödri I
    Neurol Psihiatr Neurochir; 1969; 14(5):435-42. PubMed ID: 5380160
    [No Abstract]   [Full Text] [Related]  

  • 14. [Plasmatic enzyme studies in individuals with progressive muscular dystrophy in the course of various therapeutic trials].
    Mancini G; Lapi AS; Schwarzenberg TL; Canibus R; Natoli V
    Arch Ital Pediatr Pueric; 1968; 26(1):36-46. PubMed ID: 5737311
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the therapy of muscular diseases].
    Mittelbach F; Bodechtel G
    Munch Med Wochenschr; 1968 Sep; 110(36):1988-93. PubMed ID: 5695705
    [No Abstract]   [Full Text] [Related]  

  • 16. [Progressive muscular dystrophy].
    Tsuji S; Kato F; Osawa K
    Naika; 1967 Jun; 19(6):1301-3. PubMed ID: 4865513
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapeutic possibilities in progressive muscular dystrophy].
    Beckmann R; von Osten V
    Dtsch Med Wochenschr; 1966 Jan; 91(3):108-16. PubMed ID: 5901816
    [No Abstract]   [Full Text] [Related]  

  • 18. [New aspects of the management of progressive muscular dystrophy].
    Tilscher H; Schenk S
    Wien Med Wochenschr; 1967 Nov; 117(44):1000-2. PubMed ID: 5591872
    [No Abstract]   [Full Text] [Related]  

  • 19. [STUDY OF SIDEREMIA IN SUBJECTS WITH PROGRESSIVE MUSCULAR DYSTROPHY IN BASIC CONDITIONS AND AFTER RE-METABOLIZING THERAPY].
    BUSCAINO GA; SPADETTA V
    Acta Neurol (Napoli); 1964; 19():509-22. PubMed ID: 14208395
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the effect of corticoid administration on creatine phosphokinase in progressive muscular dystrophy].
    Barthelmai W
    Verh Dtsch Ges Inn Med; 1965; 71():624-6. PubMed ID: 5877674
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.